Atea Pharmaceuticals Inc (AVIR) Stock Split History

Atea Pharmaceuticals Inc has split its stock once since its initial public offering (IPO). The stock split of Atea Pharmaceuticals Inc occurred on February 14, 2018 on a 1-for-11 basis, meaning that for 11 shares of AVIR owned pre-split, shareholders then owned 1 share.

This action has increased the stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only changes the number of shares and the price per share with no impact on Atea Pharmaceuticals Inc's total market capitalization.

The answer will depend on the decisions of the company's managers and market volatility. Atea Pharmaceuticals Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when AVIR stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Atea Pharmaceuticals Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.